| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0651757B1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds |
| 01/29/1997 | EP0635015B1 Acylaminoindole derivatives as 5-ht1 agonists |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0544748B1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
| 01/29/1997 | EP0501997B1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 01/29/1997 | CN1141650A Macroencapsulated secretory cells |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141593A Medical apptication of bromelain |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CN1141170A Compound prepn. contg. multi vitamins, minerals and trace elements suitable for Chinese people |
| 01/28/1997 | US5597915 Antagonists of cholecystokinin and gastrin receptors |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597815 Prevention of hyperphosphatemia in kidney disorder patients |
| 01/28/1997 | US5597796 Transdermal insulin |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597550 Apparatus and method for administering minerals |
| 01/28/1997 | CA2181422A1 Fenofibrate galenic formulations and uses thereof |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002269A1 Condensed thiazole derivatives, having 5-ht receptor affinity |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002052A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002043A1 Prevention of a disease having the characteristics of diabetes |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002004A2 Methods for treating diabetes |
| 01/23/1997 | WO1997001959A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | CA2225454A1 Methods for treating diabetes |
| 01/23/1997 | CA2222725A1 Therapeutic agents |
| 01/22/1997 | EP0754457A1 Antiobestic agent |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754051A1 Therapeutic agent for disorder of lipid metabolism |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
| 01/22/1997 | EP0754042A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
| 01/22/1997 | EP0754035A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 01/22/1997 | EP0699187B1 Beta,beta-dimethyl-4-piperidineethanamine derivatives as inhibitors of the cholesterol biosynthesis |
| 01/22/1997 | EP0546007B1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
| 01/22/1997 | CN1140995A Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595995 Anticarcinogenic agents |
| 01/21/1997 | US5595872 Dna sequences, cells and expression vectors |
| 01/21/1997 | US5595743 Preparation of herbal medicines by using a multi-enzyme system, herbal medicines prepared and their uses |
| 01/21/1997 | CA2123059C Method of lowering blood lipid levels |
| 01/21/1997 | CA2118133C Aminoguanidine spray drying process |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001551A1 Pyrazole compounds and pharmaceutical compositions |
| 01/16/1997 | WO1997001549A1 Benzothiophene compounds |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2220991A1 Benzothiophene compounds |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753526A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 01/15/1997 | EP0753517A2 Amides and sulfonamides of benzylamines with heterocyclic substituents |
| 01/15/1997 | EP0753302A1 Osteoporosis preventing or treating agent |
| 01/15/1997 | EP0753298A1 Synergistic combination comprising an insulin sensitizer and a HMG-CoA reductase inhibitor for treating arteriosclerosis |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752999A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752988A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752856A1 Methods of treating hyperlipidemia |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140411A Oral liquid compositions contg. paroxetine resinate |
| 01/15/1997 | CN1140084A Medicine for treatment of diabetes mellitus and its preparing process |
| 01/14/1997 | US5594157 Process for making taxol derivatives |
| 01/14/1997 | US5594154 5-amino-2-bromomethyl-2,4,6,7-tetramethyl-2,3-dihydrobenzo(b) furans |
| 01/14/1997 | US5594101 Anti-obesity proteins |
| 01/14/1997 | US5594027 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| 01/14/1997 | US5594014 Indole derivatives as 5-HT1 agonists |
| 01/14/1997 | US5594005 Use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/14/1997 | US5593962 Treating calcium deficiency |
| 01/14/1997 | US5593960 Producing cyclomarin a from fermentation of streptomyces |
| 01/14/1997 | CA2111096C Thiazolidinedione hypoglycemic agents |
| 01/14/1997 | CA2053880C Treatment of motility disorders with a gnrh analog |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/08/1997 | EP0752391A2 Water for medical treatment, production method thereof and dialysis apparatus using same |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751961A1 Eating suppressant peptides |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751944A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents |
| 01/08/1997 | EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 01/08/1997 | EP0751934A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |